Internship M&A (f/m/d) starting in January 2027
Internship M&A (f/m/d) starting in January 2027
Internship M&A (f/m/d) starting in January 2027
Internship M&A (f/m/d) starting in January 2027
Adragos Pharma
Pharmazeutische Produkte, Arzneimittel
München
- Art der Beschäftigung: Studierende
- Vor Ort
Internship M&A (f/m/d) starting in January 2027
Über diesen Job
Internship M&A (f/m/d) starting in January 2027
München, Deutschland
Your mission
- You will work on complex, cross-border M&A transactions from day 1.
- You create an M&A funnel, the so-called deal flow.
- You maintain and design financial and valuation models.
- You support the team in commercial and financial DDs.
- You design and conduct market and company analyses.
Your profile
- You are studying Business administration or Economics, ideally with a focus on Finance, M&A, or Accounting and are interested in the pharmaceutical industry.
- You have already gained M&A or corporate finance experience through internships in Investment Banking or Strategy Consulting.
- Very good analytical, conceptual, and communication skills as well as team spirit.
- You have Microsoft Powerpoint and Excel know-how as well as a good portion of common sense.
- You are proficient in English, other languages are a plus.
About us
Adragos Pharma is a reliable Contract Development and Manufacturing Organization (CDMO) headquartered in Munich, Germany. We provide comprehensive development and manufacturing services for drug products, including sterile and non-sterile liquids, solids, and semi-solids. Our expertise also covers biologicals, orphan drugs, clinical trials, fill-and-finish, and lyophilization, offering end-to-end solutions from product development to commercial supply.
With production sites in Germany, France, Greece, Norway, Japan, and Switzerland, we ensure high-quality manufacturing across all stages of the drug development process.
Founded in 2020, Adragos Pharma has rapidly grown through an ambitious buy & build strategy, supported by FSN Capital. With a team of over 900 professionals, we are expanding our operations across Europe, North America, and Japan to become a global leader in the CDMO sector.
As a key player in the pharmaceutical industry, CDMOs like Adragos produce 25% of all drugs globally, ensuring access to essential medications. With increasing healthcare demands, we continue to innovate and set new standards in drug manufacturing.
You want to be part of our dynamic growth? Then apply now!
With production sites in Germany, France, Greece, Norway, Japan, and Switzerland, we ensure high-quality manufacturing across all stages of the drug development process.
Founded in 2020, Adragos Pharma has rapidly grown through an ambitious buy & build strategy, supported by FSN Capital. With a team of over 900 professionals, we are expanding our operations across Europe, North America, and Japan to become a global leader in the CDMO sector.
As a key player in the pharmaceutical industry, CDMOs like Adragos produce 25% of all drugs globally, ensuring access to essential medications. With increasing healthcare demands, we continue to innovate and set new standards in drug manufacturing.
You want to be part of our dynamic growth? Then apply now!
